发明名称 |
GLP-1 as a diagnostic test to determine beta-cell function and the presence of the condition of IGT and type-II diabetes |
摘要 |
Since glucagon-like peptide-1 (GLP-1) is the most potent insulinotropic hormone known and has been shown to stimulate insulin secretion strongly in patients with type II diabetes, this invention uses GLP-1 or its biologically active analogues in beta-cell stimulatory tests in order to test beta-cell function in a simple way. The test provides information about insulin secretory capacity, is easy and reproducible and has insignificant side effects.
|
申请公布号 |
US6884579(B2) |
申请公布日期 |
2005.04.26 |
申请号 |
US20010055259 |
申请日期 |
2001.10.26 |
申请人 |
AMYLIN PHARMACEUTICALS, INC. |
发明人 |
HOLST JENS J.;VILSBOLL TINA |
分类号 |
A61K49/00;C07K14/605;(IPC1-7):C12Q1/68 |
主分类号 |
A61K49/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|